Biogen
Clinical trials sponsored by Biogen, explained in plain language.
-
New hope for SMA babies: boosting gene therapy with a Follow-Up drug
Disease control Not yet recruitingThis study tests a drug called salanersen in babies with spinal muscular atrophy (SMA) who have already received gene therapy. The drug aims to help the body make more SMN protein, which is needed for muscle function. About 42 babies with two copies of the SMN2 gene will be rando…
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for kids with MS: safer drug combo aims to stop relapses
Disease control Not yet recruitingThis study tests two drugs, diroximel fumarate and dimethyl fumarate, in children with relapsing multiple sclerosis. About 185 kids will be split by weight and randomly assigned to one of the drugs or a standard treatment (fingolimod). The goal is to see which drug is safer and b…
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
First human test of BIIB144 begins: safety first
Knowledge-focused Not yet recruitingThis study is the first time the experimental drug BIIB144 is given to humans. Researchers want to see if a single dose is safe and how the body handles it. About 48 healthy adults will receive either BIIB144 or a placebo by IV. The results will help decide if and how to test the…
Phase: PHASE1 • Sponsor: Biogen • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC